205 related articles for article (PubMed ID: 31525442)
21. Lysine-mediated hydroxyethyl starch-10-hydroxy camptothecin micelles for the treatment of liver cancer.
Li G; Zhao M; Zhao L
Drug Deliv; 2020 Dec; 27(1):519-529. PubMed ID: 32228107
[TBL] [Abstract][Full Text] [Related]
22. A study of the synergistic effect of folate-decorated polymeric micelles incorporating Hydroxycamptothecin with radiotherapy on xenografted human cervical carcinoma.
You H; Fu S; Qin X; Yu Y; Yang B; Zhang G; Sun X; Feng Y; Chen Y; Wu J
Colloids Surf B Biointerfaces; 2016 Apr; 140():150-160. PubMed ID: 26752212
[TBL] [Abstract][Full Text] [Related]
23. Hydroxyethyl starch conjugates for improving the stability, pharmacokinetic behavior and antitumor activity of 10-hydroxy camptothecin.
Li G; Li Y; Tang Y; Zhang Y; Zhang Y; Yin T; Xu H; Cai C; Tang X
Int J Pharm; 2014 Aug; 471(1-2):234-44. PubMed ID: 24861941
[TBL] [Abstract][Full Text] [Related]
24. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
25. Lipid nanoparticles loaded with 10-hydroxycamptothecin-phospholipid complex developed for the treatment of hepatoma in clinical application.
Wei W; Shi SJ; Liu J; Sun X; Ren K; Zhao D; Zhang XN; Zhang ZR; Gong T
J Drug Target; 2010 Aug; 18(7):557-66. PubMed ID: 20131981
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo anti-tumor efficacy of 10-hydroxycamptothecin polymorphic nanoparticle dispersions: shape- and polymorph-dependent cytotoxicity and delivery of 10-hydroxycamptothecin to cancer cells.
Wang H; Feng J; Liu G; Chen B; Jiang Y; Xie Q
Nanomedicine; 2016 May; 12(4):881-891. PubMed ID: 26767513
[TBL] [Abstract][Full Text] [Related]
27. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice.
Zhang L; Yang M; Wang Q; Li Y; Guo R; Jiang X; Yang C; Liu B
J Control Release; 2007 Jun; 119(2):153-62. PubMed ID: 17400320
[TBL] [Abstract][Full Text] [Related]
28. Antitumor activities of emulsion electrospun fibers with core loading of hydroxycamptothecin via intratumoral implantation.
Luo X; Xie C; Wang H; Liu C; Yan S; Li X
Int J Pharm; 2012 Apr; 425(1-2):19-28. PubMed ID: 22265915
[TBL] [Abstract][Full Text] [Related]
29. [Experimental studies on treatment of nasopharyngeal carcinoma with combination regimen of hydroxycamptothecin and etoposide].
Liang YJ; Fu LW; Ding Y; Xiong HY; Chen LM; Yang XP; Pan QC
Ai Zheng; 2003 Apr; 22(4):368-71. PubMed ID: 12703990
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Biological Evaluation of Novel Water-Soluble Poly-(ethylene glycol)-10-hydroxycamptothecin Conjugates.
Guo N; Jiang D; Wang L; You X; Teng YO; Yu P
Molecules; 2015 May; 20(5):9393-404. PubMed ID: 26007190
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, self-assembly and drug release behaviors of a bottlebrush polymer-HCPT prodrug for tumor chemotherapy.
Lv F; Liu D; Cong H; Shen Y; Yu B
Colloids Surf B Biointerfaces; 2019 Sep; 181():278-284. PubMed ID: 31154138
[TBL] [Abstract][Full Text] [Related]
32. Formulation of pluronic F127/TPGS mixed micelles to improve the oral absorption of glycyrrhizic acid.
Shen C; Zhu J; Song J; Wang J; Shen B; Yuan H; Li X
Drug Dev Ind Pharm; 2020 Jul; 46(7):1100-1107. PubMed ID: 32463722
[No Abstract] [Full Text] [Related]
33. Covalently combining carbon nanotubes with anticancer agent: preparation and antitumor activity.
Wu W; Li R; Bian X; Zhu Z; Ding D; Li X; Jia Z; Jiang X; Hu Y
ACS Nano; 2009 Sep; 3(9):2740-50. PubMed ID: 19702292
[TBL] [Abstract][Full Text] [Related]
34. Effect of alkyl chain on cellular uptake and antitumor activity of hydroxycamptothecin nanoparticles based on amphiphilic linear molecules.
Guo Y; Wang T; Zhao S; Qiu H; Han M; Dong Z; Wang X
Eur J Pharm Sci; 2018 Nov; 124():266-272. PubMed ID: 30189259
[TBL] [Abstract][Full Text] [Related]
35. Preparation of camptothecin micelles self-assembled from disodium glycyrrhizin and tannic acid with enhanced antitumor activity.
Zhang Q; Feng Z; Wang H; Su C; Lu Z; Yu J; Dushkin AV; Su W
Eur J Pharm Biopharm; 2021 Jul; 164():75-85. PubMed ID: 33878433
[TBL] [Abstract][Full Text] [Related]
36. Combating liver cancer through GO-targeted biomaterials.
Huang X; Zhang J; Song Y; Zhang T; Wang B
Biomed Mater; 2021 Sep; 16(6):. PubMed ID: 34412048
[TBL] [Abstract][Full Text] [Related]
37. Preparation, characterization, biodistribution and antitumor efficacy of hydroxycamptothecin nanosuspensions.
Han M; Liu X; Guo Y; Wang Y; Wang X
Int J Pharm; 2013 Oct; 455(1-2):85-92. PubMed ID: 23928147
[TBL] [Abstract][Full Text] [Related]
38. Mitochondria and nucleus delivery of active form of 10-hydroxycamptothecin with dual shell to precisely treat colorectal cancer.
Li HQ; Ye WL; Huan ML; Cheng Y; Liu DZ; Cui H; Liu M; Zhang BL; Mei QB; Zhou SY
Nanomedicine (Lond); 2019 Apr; 14(8):1011-1032. PubMed ID: 30925116
[TBL] [Abstract][Full Text] [Related]
39. Preparation and
Zhou T; Tang X; Zhang W; Feng J; Wu W
Drug Deliv; 2019 Dec; 26(1):673-679. PubMed ID: 31266376
[TBL] [Abstract][Full Text] [Related]
40. Polymeric micelle systems of hydroxycamptothecin based on amphiphilic N-alkyl-N-trimethyl chitosan derivatives.
Zhang C; Ding Y; Yu LL; Ping Q
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):192-9. PubMed ID: 17223019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
